Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Clinical trial NCT06705062 · RECRUITING
Trial details
- NCT number
- NCT06705062
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-12-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.